Company Overview and News

0
Binani Industries Limited - Clarification - Financial Results

2018-08-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

0
Binani Industries Limited - Financial Result Updates

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

1
Ultratech’s resolution plan for Binani Cement submitted at NCLT

2018-06-04 livemint
Kolkata: The resolution professional of Binani Cement Ltd. on Monday submitted the resolution plan of Ultratech Cement Ltd. at the Kolkata bench of the National Company Law Tribunal for its approval even as the tribunal agreed to hear Dalmia Bharat’s objections about Ultratech’s bid.
BINANIIND DALMIABHA 533309 UCLQY UCLQF 532538 500059 ULTRACEMCO

0
Binani Industries Limited - Outcome of Board Meeting

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

1
Binani lenders okay UltraTech acquisition

2018-05-31 freepressjournal.in
New Delhi : The lenders of Binani Cement have issued letter of intent to UltraTech after approving its bid to acquire the company under the bankruptcy code, Aditya Birla group firm said on Wednesday. The Committee of Creditors (CoC) of Binani Cement on May 28 approved the resolution Plan submitted by UltraTech Cement, it said.
BINANIIND UCLQY UCLQF 532538 500059 ULTRACEMCO

1
Binani Cement lenders back UltraTech’s offer

2018-05-28 livemint
Mumbai: UltraTech Cement Ltd’s Rs7,950 crore bid to acquire Binani Cement Ltd has received near-unanimous backing from lenders to the distressed building material maker even as a legal battle reached the country’s top court, two people aware of the development said.
BINANIIND DALMIABHA 533309 UCLQY UCLQF 532538 PRMQY 500059 500302 ULTRACEMCO PEL

4
Binani Cement lenders vote in favour of UltraTech offer

2018-05-28 moneycontrol
The committee of creditors (CoC) for Binani Cement May 28 voted in favour of accepting UltraTech Cement’s Rs 7,950 crore bid.
BINANIIND 500116 DALMIABHA 533309 UCLQY IDBI UCLQF 532538 500059 ULTRACEMCO SBAZ

1
NCLAT refuses to stay Binani Cement insolvency proceedings

2018-05-22 livemint
New Delhi:The National Company Law Appellate Tribunal (NCLAT) on Tuesday refused to stay the corporate insolvency resolution process for Binani Cement Ltd.
BINANIIND UCLQY UCLQF 532538 500059 ULTRACEMCO

0
Binani Ind offers to repay 100% debt of cement unit

2018-05-17 freepressjournal.in
New Delhi : Binani Industries, which holds a 98.4 per cent stake in debt-ridden Binani Cement, on Wednesday offered to clear the 100 per cent claims of creditors at the National Company Law Appellate Tribunal.
BINANIIND 500059

1
Binani Industries offers to pay 100% debt amount of Binani Cement

2018-05-16 livemint
New Delhi: Binani Industries Ltd, the parent of debt-ridden Binani Cement Ltd, told the National Company Law Appellate Tribunal (NCLAT) on Wednesday that it was ready to pay up all the dues of its subsidiary to its financial and operational creditors in two weeks, if the tribunal so permitted.
BINANIIND DALMIABHA 533309 UCLQY UCLQF 532538 500059 ULTRACEMCO

0
Binani Industries Limited - Shareholders meeting

2018-05-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

0
Binani Cement#39;s lenders call off meeting after Dalmia#39;s objection

2018-05-10 moneycontrol
A scheduled meeting of Binani Cement's lenders for Thursday has been postponed after Dalmia Bharat alleged that UltraTech is ineligible from participating in the auction.
BINANIIND DALMIABHA 533309 500059

3
Lenders fret as insolvency cases miss deadlines, hope delays yield better returns

2018-05-04 moneycontrol
The fate of a few of the 12 stressed accounts facing insolvency proceedings — including Essar Steel and Binani Cement — hangs in the balance as court cases are delaying the resolution process beyond the stipulated deadline of 270 days.
ESL BINANIIND KMBKY BHUSANSTL 533264 532538 UCLQF 513216 532778 ULTRACEMCO UTTAMSTL UCLQY KOTAKBANK 500059 500247 LITL 500055

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...